Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
27.68
-0.70 (-2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
Next >
Lululemon, Smartsheet, Okta, And Other Big Gainers From Friday
September 06, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Friday. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket
August 26, 2022
Gainers
Via
Benzinga
Analyst Ratings for Guardant Health
August 25, 2022
Within the last quarter, Guardant Health (NASDAQ:GH) has observed the following analyst ratings:
Via
Benzinga
Recap: Guardant Health Q2 Earnings
August 04, 2022
Guardant Health (NASDAQ:GH) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
Guardant Health's Return On Capital Employed Insights
August 23, 2022
Benzinga Pro data, Guardant Health (NASDAQ:GH) reported Q2 sales of $109.14 million. Earnings fell to a loss of $229.43 million, resulting in a 86.18% decrease from last quarter.
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 12, 2022
Via
Benzinga
Recap: Guardant Health Q4 Earnings
February 23, 2022
Guardant Health (NASDAQ:GH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:03 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Via
Benzinga
Uber Dumped By Large Shareholder As Billionaire's 'Vision' Suffers Investment Struggles
August 08, 2022
After reporting one of its largest losses ever, SoftBank Group Corp (OTC: SFTBY) has turned to alternative methods to regain lost capital.
Via
Benzinga
5 Top Stocks Cathie Wood Bought This Week
July 29, 2022
Despite a 50% YTD drawdown in ARKK, Cathie Wood has continued her purchases of high growth companies, such as TDOC and BILL stocks.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 12, 2022
Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 07, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
June 03, 2022
Via
Benzinga
10 Biggest Price Target Changes For Monday
May 09, 2022
Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.
Via
Benzinga
90 Biggest Movers From Yesterday
May 10, 2022
Gainers
Via
Benzinga
92 Biggest Movers From Friday
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Guardant Health
May 06, 2022
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 07, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Guardant Health's Return On Capital Employed Overview
March 11, 2022
According to data from Benzinga Pro, during Q4, Guardant Health's (NASDAQ:GH) reported sales totaled $108.11 million. Despite a 32.75% increase in earnings, the company posted a...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
February 24, 2022
SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading.
Via
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
Why Jim Cramer Likes Vertiv And Scotts Miracle-Gro
January 07, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Vertiv Holdings Co (NYSE:
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
4 Stocks Insiders Are Buying
November 24, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
68 Biggest Movers From Wednesday
November 26, 2021
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.